Skip to main navigation Skip to search Skip to main content

IFI44 Orchestrates an IL-10–Driven M2 Macrophage Program in Breast Cancer: An Immune Prognostic Signature

Press/Media: Press / Media

PeriodApr 7 2026

Media coverage

1

Media coverage

  • TitleIFI44 Orchestrates an IL-10–Driven M2 Macrophage Program in Breast Cancer: An Immune Prognostic Signature
    Media name/outletDove Medical Press
    Country/TerritoryUnited Kingdom
    Date4/7/26
    PersonsHaimin Wang
View all 1
View less